Sobi raises revenue outlook as third quarter beats estimates; shares gain
AI Summary
Swedish pharmaceutical company Sobi raised its revenue outlook after third-quarter results exceeded estimates, and its shares gained. The headline does not provide the revised forecast or identify the products driving performance.